Last 7 days
-2.1%
Last 30 days
-4.9%
Last 90 days
-14.6%
Trailing 12 Months
-30.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HCA | 73.0B | 60.9B | -4.91% | 25.24% | 12.73 | 1.2 | 1.94% | -15.77% |
LH | 20.7B | 14.8B | -2.77% | -13.32% | 16.22 | 1.39 | -6.96% | -52.35% |
DGX | 15.0B | 9.6B | -8.90% | -4.59% | 18.89 | 1.56 | -10.08% | -57.84% |
MID-CAP | ||||||||
UHS | 9.9B | 13.6B | -10.37% | 3.84% | 14.64 | 0.74 | 5.04% | -26.87% |
DVA | 8.5B | 11.7B | 9.28% | -3.24% | 16.63 | 0.73 | 0.42% | -43.11% |
THC | 7.2B | 19.4B | -1.91% | 7.28% | 7.07 | 0.37 | 0.01% | -33.70% |
EHC | 6.1B | 4.4B | -5.92% | 18.26% | 22.47 | 1.4 | 8.15% | -30.89% |
SGRY | 4.5B | 2.6B | -10.50% | -11.04% | -48.8 | 1.71 | 13.01% | -143.24% |
SEM | 3.4B | 6.4B | -7.51% | 11.50% | 19.08 | 0.54 | 2.26% | -46.98% |
SMALL-CAP | ||||||||
RDNT | 1.7B | 1.5B | 6.01% | 44.82% | -126.07 | 1.14 | 10.24% | -173.11% |
ADUS | 1.4B | 976.1M | -21.09% | 3.91% | 28.65 | 1.47 | 10.19% | 12.37% |
BKD | 645.6M | 2.9B | -18.53% | -39.08% | -3.53 | 0.22 | 7.97% | -101.02% |
CYH | 419.8M | 12.2B | -47.61% | -42.62% | -104.96 | 0.03 | -2.06% | -101.36% |
SSY | 6.7M | 46.8M | -7.74% | -13.61% | -2.44 | 0.14 | 12.07% | -154.21% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 0.4% | 1,981 | 1,972 | 1,957 | 1,960 | 1,947 |
Operating Expenses | 1.0% | 1,817 | 1,799 | 1,752 | 1,744 | 1,731 |
S&GA Expenses | -1.0% | 229 | 231 | 239 | 248 | 258 |
EBITDA | -16.5% | 157 | 188 | 200 | 202 | - |
EBITDA Margin | -17.2% | 0.08* | 0.10* | 0.10* | 0.10* | - |
Earnings Before Taxes | 60.3% | 130 | 81.00 | 107 | 112 | 106 |
EBT Margin | -24.6% | 0.04* | 0.05* | 0.06* | 0.05* | - |
Interest Expenses | -3.6% | 38.00 | 40.00 | 46.00 | 54.00 | 63.00 |
Net Income | 53.4% | 102 | 66.00 | 84.00 | 84.00 | 92.00 |
Net Income Margin | -21.8% | 0.03* | 0.04* | 0.04* | 0.05* | - |
Free Cahsflow | 48.4% | 167 | 112 | 90.00 | 61.00 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | -1.2% | 2,320 | 2,348 | 2,332 | 2,370 | 2,341 |
Current Assets | -4.5% | 409 | 428 | 424 | 459 | 440 |
Cash Equivalents | -37.7% | 6.00 | 10.00 | 9.00 | 14.00 | 7.00 |
Net PPE | -0.5% | 73.00 | 73.00 | 72.00 | 72.00 | 72.00 |
Goodwill | 0% | 1,532 | 1,532 | 1,532 | 1,532 | 1,529 |
Liabilities | -3.2% | 1,410 | 1,456 | 1,473 | 1,524 | 1,464 |
Current Liabilities | -33.4% | 284 | 427 | 352 | 329 | 270 |
Shareholder's Equity | 2.0% | 910 | 892 | 859 | 845 | 877 |
Retained Earnings | 16.0% | -74.86 | -89.06 | -118 | -149 | -176 |
Additional Paid-In Capital | 0.3% | 987 | 984 | 981 | 997 | 1,054 |
Shares Outstanding | 0.8% | 84.00 | 83.00 | 83.00 | 84.00 | 87.00 |
Minority Interest | NaN% | - | - | - | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | -2.1% | 164 | 167 | 112 | 90.00 | 61.00 |
Share Based Compensation | -8.8% | 15.00 | 16.00 | 17.00 | 18.00 | 20.00 |
Cashflow From Investing | 26.2% | -42.03 | -56.95 | -61.30 | -96.42 | -68.98 |
Cashflow From Financing | 74.9% | -122 | -487 | -400 | -317 | -254 |
Buy Backs | -0.4% | 88.00 | 89.00 | 87.00 | 68.00 | 4.00 |
100%
84.2%
63.9%
Y-axis is the maximum loss one would have experienced if MEDNAX was unfortunately bought at previous high price.
-11.7%
-20.8%
-22.2%
-5.6%
FIve years rolling returns for MEDNAX.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-26 | ProShare Advisors LLC | reduced | -8.15 | -15,040 | 176,862 | -% |
2023-05-25 | Legato Capital Management LLC | unchanged | - | 1,426 | 425,382 | 0.08% |
2023-05-23 | Capital Impact Advisors, LLC | added | 6.26 | 37,591 | 605,763 | 0.74% |
2023-05-22 | AMERIPRISE FINANCIAL INC | reduced | -1.54 | -79,701 | 6,614,300 | -% |
2023-05-18 | JPMORGAN CHASE & CO | added | 19.32 | 306,000 | 1,857,000 | -% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -3.22 | -668,000 | 22,438,000 | 0.03% |
2023-05-17 | Advisory Services Network, LLC | sold off | - | - | - | -% |
2023-05-17 | Thrivent Financial for Lutherans | reduced | -3.38 | -38,000 | 1,213,000 | -% |
2023-05-16 | SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | sold off | -100 | -805,100 | - | -% |
2023-05-16 | CAROLINAS WEALTH CONSULTING LLC | unchanged | - | 11.00 | 3,221 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
May 10, 2023 | alliancebernstein l.p. | 10.0% | 8,392,304 | SC 13G/A | |
Feb 14, 2023 | alliancebernstein l.p. | 7.8% | 6,468,122 | SC 13G/A | |
Feb 14, 2023 | earnest partners llc | 7.9% | 6,546,580 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 11.72% | 9,738,017 | SC 13G/A | |
Jan 23, 2023 | blackrock inc. | 16.5% | 13,672,143 | SC 13G/A | |
Jan 20, 2023 | starboard value lp | 4.0% | 3,348,578 | SC 13D/A | |
Dec 02, 2022 | starboard value lp | 7.1% | 5,915,000 | SC 13D/A | |
Feb 14, 2022 | arrowmark colorado holdings llc | 3.10% | 2,683,879 | SC 13G/A | |
Feb 14, 2022 | alliancebernstein l.p. | 8.5% | 7,359,083 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 11.32 -15.27% | 14.02 4.94% | 20.33 52.17% | 26.00 94.61% | 30.28 126.65% |
Current Inflation | 10.98 -17.81% | 13.52 1.20% | 19.29 44.39% | 24.45 83.01% | 27.50 105.84% |
Very High Inflation | 10.53 -21.18% | 12.86 -3.74% | 17.95 34.36% | 22.49 68.34% | 24.17 80.91% |
Date Filed | Form Type | Document | |
---|---|---|---|
May 26, 2023 | 4 | Insider Trading | |
May 24, 2023 | 144 | Notice of Insider Sale Intent | |
May 22, 2023 | 4 | Insider Trading | |
May 19, 2023 | 144 | Notice of Insider Sale Intent | |
May 18, 2023 | 144 | Notice of Insider Sale Intent | |
May 15, 2023 | 4 | Insider Trading | |
May 15, 2023 | 4 | Insider Trading | |
May 15, 2023 | 4 | Insider Trading | |
May 15, 2023 | 4 | Insider Trading | |
May 15, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-05-25 | ORDAN MARK S | sold | -437,580 | 13.26 | -33,000 | - |
2023-05-19 | Weis Shirley A | sold | -13,725 | 13.63 | -1,007 | - |
2023-05-18 | Weis Shirley A | sold | -243,805 | 13.55 | -17,993 | - |
2023-05-15 | Pickert Curtis | gifted | - | - | -5,984 | evp, chief operating officer |
2023-05-12 | Young Sylvia Jean | acquired | - | - | 10,831 | - |
2023-05-11 | Starcher John M. Jr. | acquired | - | - | 10,965 | - |
2023-05-11 | Linynsky Laura A | acquired | - | - | 10,965 | - |
2023-05-11 | SANSONE GUY P | acquired | - | - | 10,965 | - |
2023-05-11 | Weis Shirley A | acquired | - | - | 10,965 | - |
2023-05-11 | Rucker Michael A. | acquired | - | - | 10,965 | - |
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |||
Income Statement [Abstract] | ||||
Net revenue | $ 491,008 | $ 482,229 | ||
Operating expenses: | ||||
Practice salaries and benefits | 362,235 | 343,155 | ||
Practice supplies and other operating expenses | 30,720 | 28,489 | ||
General and administrative expenses | 59,059 | 61,287 | ||
Depreciation and amortization | 8,953 | 8,769 | ||
Transformational and restructuring related expenses | 0 | 1,421 | ||
Total operating expenses | 460,967 | 443,121 | ||
Income from operations | 30,041 | 39,108 | ||
Investment and other income | 634 | 875 | ||
Interest expense | (10,390) | (11,818) | ||
Loss on early extinguishment of debt | 0 | (57,016) | ||
Equity in earnings of unconsolidated affiliate | 427 | 505 | ||
Total non-operating expenses | (9,329) | (67,454) | ||
Income (loss) from continuing operations before income taxes | 20,712 | (28,346) | ||
Income tax benefit | (6,506) | 7,401 | ||
Income (loss)from continuing operations | 14,206 | (20,945) | ||
Loss from discontinued operations, net of tax | 0 | (247) | ||
Net Income (loss) | 14,206 | (21,192) | ||
Net loss attributable to noncontrolling interest | 0 | 4 | ||
Net Income (loss) attributable to Pediatrix Medical Group, Inc. | 14,206 | (21,188) | ||
Unrealized holding gain (loss) on investments, net of tax of $227 and $894 | 604 | (2,668) | ||
Total comprehensive income (loss) attributable to Pediatrix Medical Group, Inc. | $ 14,810 | $ (23,856) | ||
Net (loss) income attributable to Pediatrix Medical Group, Inc.: | ||||
Basic | $ 0.17 | $ (0.25) | ||
Diluted | $ 0.17 | $ (0.25) | ||
Weighted average common shares: | ||||
Basic | 81,894 | 85,405 | ||
Diluted | [1] | 82,318 | 85,405 | |
|
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 6,124 | $ 9,824 |
Short-term investments | 96,709 | 93,239 |
Accounts receivable, net | 278,739 | 296,787 |
Prepaid expenses | 14,951 | 14,878 |
Other current assets | 12,069 | 13,261 |
Total current assets | 408,592 | 427,989 |
Property and equipment, net | 72,928 | 73,290 |
Goodwill | 1,532,092 | 1,532,092 |
Intangible assets, net | 17,487 | 18,491 |
Operating and finance lease right-of-use assets | 66,793 | 66,924 |
Deferred income tax assets | 102,778 | 105,925 |
Other assets | 119,381 | 123,176 |
Total assets | 2,320,051 | 2,347,887 |
Current liabilities: | ||
Accounts payable and accrued expenses | 226,675 | 374,225 |
Current portion of debt and finance lease liabilities, net | 14,914 | 14,898 |
Current portion of operating lease liabilities | 21,058 | 21,589 |
Income taxes payable | 21,571 | 16,271 |
Total current liabilities | 284,218 | 426,983 |
Line of credit | 114,000 | 4,000 |
Long-term debt and finance lease liabilities, net | 628,814 | 632,381 |
Long-term operating lease liabilities | 43,977 | 44,213 |
Long-term professional liabilities | 268,922 | 275,629 |
Deferred income tax liabilities | 32,703 | 33,638 |
Other liabilities | 37,646 | 39,411 |
Total liabilities | 1,410,280 | 1,456,255 |
Commitments and contingencies | ||
Shareholders' equity: | ||
Preferred stock; $.01 par value; 1,000 shares authorized; none issued | 0 | 0 |
Common stock; $.01 par value; 200,000 shares authorized; 83,634 and 82,947 sharesissued and outstanding, respectively | 836 | 829 |
Additional paid-in capital | 986,923 | 983,601 |
Accumulated other comprehensive loss | (3,131) | (3,735) |
Retained deficit | (74,857) | (89,063) |
Total shareholders' equity | 909,771 | 891,632 |
Total liabilities and shareholders' equity | $ 2,320,051 | $ 2,347,887 |